Citizens Financial Group Inc Edwards Lifesciences Corp Transaction History

Citizens Financial Group Inc

$4.91 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$81.41 - $94.33 $256,441 - $297,139	-3,150 Reduced 53.79%	2,706 $255,000
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $41,362 - $47,072	-557 Reduced 8.69%	5,856 $484,000
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $149,986 - $192,018	-2,196 Reduced 25.51%	6,413 $478,000
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $334,010 - $435,060	-4,055 Reduced 32.02%	8,609 $711,000
Q2 2022 Aug 05, 2022	SELL	$86.5 - $128.27 $46,623 - $69,137	-539 Reduced 4.08%	12,664 $1.2 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $138,359 - $174,157	1,357 Added 11.46%	13,203 $1.55 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $72,437 - $88,993	-681 Reduced 5.44%	11,846 $1.54 Million
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $845,817 - $1.01 Million	8,219 Added 190.78%	12,527 $1.42 Million
Q2 2021 Aug 04, 2021	SELL	$83.84 - $104.76 $410,983 - $513,533	-4,902 Reduced 53.22%	4,308 $446,000
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $9.7 Million - $11.2 Million	-123,263 Reduced 93.05%	9,210 $770,000
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $170,980 - $217,583	-2,385 Reduced 1.77%	132,473 $12.1 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $153,461 - $199,712	2,284 Added 1.72%	134,858 $10.8 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $5.04 Million - $6.73 Million	87,512 Added 194.2%	132,574 $9.16 Million
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $141,454 - $218,619	-2,699 Reduced 5.65%	45,062 $8.5 Million
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $177,744 - $203,501	-2,479 Reduced 4.93%	47,761 $11.1 Million
Q3 2019 Nov 01, 2019	SELL	$61.55 - $75.43 $53,363 - $65,397	-867 Reduced 1.7%	50,240 $11 Million
Q2 2019 Aug 09, 2019	SELL	$55.74 - $64.41 $89,406 - $103,313	-1,604 Reduced 3.04%	51,107 $9.44 Million
Q1 2019 May 09, 2019	BUY	$47.89 - $64.05 $91,326 - $122,143	1,907 Added 3.75%	52,711 $10.1 Million
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $25,757 - $31,601	-555 Reduced 1.08%	50,804 $7.78 Million
Q3 2018 Nov 02, 2018	SELL	$45.7 - $58.03 $15,857 - $20,136	-347 Reduced 0.67%	51,359 $8.94 Million
Q2 2018 Jul 27, 2018	SELL	$42.45 - $51.3 $56,925 - $68,793	-1,341 Reduced 2.53%	51,706 $7.53 Million
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $1.97 Million - $2.52 Million	53,047 New	53,047 $7.4 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account